0001567619-20-004465.txt : 20200220
0001567619-20-004465.hdr.sgml : 20200220
20200220164742
ACCESSION NUMBER: 0001567619-20-004465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200218
FILED AS OF DATE: 20200220
DATE AS OF CHANGE: 20200220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASAR VINIT K
CENTRAL INDEX KEY: 0001454324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 20635898
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2020-02-18
0
0000722723
HANGER, INC.
HNGR
0001454324
ASAR VINIT K
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
1
0
0
President and CEO
Common Stock
2020-02-18
4
A
0
73987
0
A
661995
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
159982
159982
D
Performance Share Units
2020-05-19
Common Stock
63993
63993
D
Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2019 and ending on December 31, 2019. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
Includes (i) unvested restricted shares totaling 73,987 shares of stock from an initial grant of 73,987 shares of restricted stock which begins to vest on March 8, 2020; (ii) unvested restricted shares totaling 58,456 shares of stock from an initial grant of 58,456 shares of restricted stock which begins to vest on March 8, 2020; (iii) unvested restricted shares and fully vested shares totaling 72,638 shares of stock from an initial grant of 80,564 shares of restricted stock made on March 9, 2018; (iv) unvested restricted shares and fully vested shares totaling 75,906 shares of stock from an initial grant of 94,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 60,874 shares of stock from an initial grant of 67,516 shares of restricted stock made on March 9, 2018; (vi) fully vested shares totaling 65,566 shares of stock from an initial grant of 95,376 shares of restricted stock made on March 6, 2015; (vii) unvested restricted shares and fully vested shares totaling 48,194 shares of stock from an initial grant of 60,000 shares of restricted stock made on March 8, 2017; (viii) unvested restricted shares and fully vested shares totaling 44,091 shares of stock from an initial grant of 60,000 shares of restricted stock made on April 29, 2016; [continued in next footnote]
(ix) fully vested shares totaling 32,807 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; (x) fully vested shares totaling 13,746 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (xi) fully vested shares totaling 21,971 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; (xii) fully vested shares totaling 14,230 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; [continued in next footnote]
(xiii) fully vested shares totaling 19,638 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (xiv) fully vested shares totaling 11,589 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (xv) fully vested shares totaling 16,600 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; and (xvi) fully vested shares totaling 29,002 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar
2020-02-20